CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections
Authors
Cornberg, MarkusClute, Shalyn Catherine
Watkin, Levi B.
Saccoccio, Frances M.
Kim, Sung-Kwon
Naumov, Yuri N.
Brehm, Michael A.
Aslan, Nuray
Welsh, Raymond M.
Selin, Liisa K.
Student Authors
Levi B. WatkinUMass Chan Affiliations
Department of PathologyDocument Type
Journal ArticlePublication Date
2010-03-15
Metadata
Show full item recordAbstract
In this study, we demonstrate complex networks of CD8 T cell cross-reactivities between influenza A virus and EBV in humans and between lymphocytic choriomeningitis virus and vaccinia virus in mice. We also show directly that cross-reactive T cells mediate protective heterologous immunity in mice. Subsets of T cell populations reactive with one epitope cross-reacted with either of several other epitopes encoded by the same or the heterologous virus. Human T cells specific to EBV-encoded BMLF1(280-288) could be cross-reactive with two influenza A virus or two other EBV epitopes. Mouse T cells specific to the vaccinia virus-encoded a11r(198-205) could be cross-reactive with three different lymphocytic choriomeningitis virus, one Pichinde virus, or one other vaccinia virus epitope. Patterns of cross-reactivity differed among individuals, reflecting the private specificities of the host's immune repertoire and divergence in the abilities of T cell populations to mediate protective immunity. Defining such cross-reactive networks between commonly encountered human pathogens may facilitate the design of vaccines.Source
J Immunol. 2010 Mar 15;184(6):2825-38. Epub 2010 Feb 17.
DOI
10.4049/jimmunol.0902168Permanent Link to this Item
http://hdl.handle.net/20.500.14038/33243PubMed ID
20164414Related Resources
ae974a485f413a2113503eed53cd6c53
10.4049/jimmunol.0902168